Videos de Experimentos Relacionados
Reflexiones sobre los siete países del estudio.
1Royal Free Hospital School of Medicine, London, UK.
Lancet (London, England)
|January 27, 1996
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Mild hyponatremia, hypernatremia and incident cardiovascular disease and mortality in older men: A population-based cohort study.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2015
Same author
Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959.
International journal of epidemiology·2012
Same author
Commentary: personal reflection on 'serum-cholesterol, diet and coronary heart-disease in Africans and Asians in Uganda'.
International journal of epidemiology·2012
Same author
Alcohol consumption decreases with the development of disease.
Addiction (Abingdon, England)·2011
Same author
Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.
Journal of thrombosis and haemostasis : JTH·2009
Same author
The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes.
Atherosclerosis·2008
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026